Ep Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

Ep Wealth Advisors, LLC

$8.44 Billion
Q1 2024

A detailed history of Ep Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 47,377 shares of BMY stock, worth $1.97 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

47,377

Previous 449,695 89.46%

Holding current value

$1.97 Million

Previous $23.1 Million 88.87%

% of portfolio

0.03%

Previous 0.3%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $19.3 Million - $21.9 Million	-402,318 Reduced 89.46%	47,377 $2.57 Million
Q4 2023 Feb 28, 2024	SELL	$48.48 - $57.85 $4.92 Million - $5.87 Million	-101,485 Reduced 18.41%	449,695 $23.1 Million
Q3 2023 Nov 22, 2023	BUY	$57.89 - $64.73 $27.7 Million - $31 Million	478,283 Added 656.11%	551,180 $32 Million
Q1 2023 Jun 05, 2023	SELL	$65.71 - $74.53 $29.2 Million - $33.1 Million	-444,080 Reduced 85.9%	72,897 $5.05 Million
Q4 2022 Jun 12, 2023	BUY	$68.48 - $81.09 $31.3 Million - $37.1 Million	456,904 Added 626.78%	529,801 $38.1 Million

Q3 2022 Dec 02, 2022	BUY	$0.13 - $76.84 $8,920 - $5.27 Million	68,617 Added 15.3%	516,977 $36.8 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $285,759 - $314,721	3,935 Added 0.89%	448,360 $34.5 Million
Q1 2022 May 20, 2022	BUY	$61.48 - $73.72 $1.07 Million - $1.28 Million	17,360 Added 4.06%	444,425 $32.5 Million
Q4 2021 Feb 17, 2022	BUY	$53.63 - $62.52 $1.29 Million - $1.51 Million	24,117 Added 5.99%	427,065 $26.6 Million
Q3 2021 Nov 23, 2021	BUY	$59.17 - $69.31 $23.1 Million - $27 Million	389,584 Added 2915.18%	402,948 $23.8 Million
Q3 2021 Nov 16, 2021	SELL	$59.17 - $69.31 $22.1 Million - $25.8 Million	-372,841 Reduced 96.54%	13,364 $23.8 Million
Q2 2021 Aug 24, 2021	BUY	$61.91 - $67.42 $1.84 Million - $2 Million	29,725 Added 8.34%	386,205 $25.8 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $5.21 Million - $5.86 Million	87,872 Added 32.71%	356,480 $22.5 Million
Q4 2020 Feb 18, 2021	BUY	$57.74 - $65.43 $1.64 Million - $1.86 Million	28,452 Added 11.85%	268,608 $16.7 Million
Q3 2020 Nov 17, 2020	BUY	$57.43 - $63.64 $1.66 Million - $1.84 Million	28,986 Added 13.73%	240,156 $14.5 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $10.9 Million - $12.7 Million	198,416 Added 1555.72%	211,170 $12.4 Million
Q1 2020 May 18, 2020	SELL	$46.4 - $67.43 $152,702 - $221,912	-3,291 Reduced 20.51%	12,754 $711,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $468,134 - $610,639	9,513 Added 145.64%	16,045 $1.03 Million
Q3 2019 Nov 18, 2019	SELL	$42.77 - $50.71 $118,986 - $141,075	-2,782 Reduced 29.87%	6,532 $331,000
Q2 2019 Aug 27, 2019	BUY	$44.62 - $49.34 $207,259 - $229,184	4,645 Added 99.49%	9,314 $422,000
Q1 2019 May 20, 2019	BUY	$45.12 - $53.8 $10,828 - $12,912	240 Added 5.42%	4,669 $223,000
Q4 2018 Feb 19, 2019	BUY	$48.76 - $63.23 $34,863 - $45,209	715 Added 19.25%	4,429 $230,000
Q3 2018 Nov 15, 2018	BUY	$55.19 - $62.25 $204,975 - $231,196	3,714 New	3,714 $231,000

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.

Account

Ep Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History